Clinical trial budgets are under increasing pressure—and in many cases, the way they are built hasn’t kept pace.

As protocols grow more complex and timelines tighten, budgeting still relies heavily on manual interpretation, data entry, and validation before negotiations can even begin. That model is becoming harder to sustain.

This was the focus of our recent webinar, Accelerating Study Budgets: Moving Beyond Manual Protocol Transcription: which explored not only where inefficiencies exist, but also how organizations can begin to modernize the budgeting process.

Today, budgeting is no longer just an administrative step. It plays a critical role in shaping study startup timelines, site relationships, and overall performance. As these pressures increase, the margin for inefficiency continues to narrow.

The real bottleneck: getting to a usable budget

For many teams, the most time-consuming part of budgeting isn’t negotiations—it’s getting to the point where a budget is ready to be reviewed.

A significant portion of effort happens upstream, as teams interpret dense protocol language, extract procedures, and translate them into structured components. Even for experienced budget builders, this can take hours before meaningful work begins.

As protocols become more detailed and study designs more complex, this front-end burden continues to grow—making it increasingly difficult to scale without adding time or resources.

This challenge is driven by a combination of factors:

• Interpreting unstructured protocol content
• Manually entering schedules of activities and events
• Mapping the appropriate activity codes

Each step introduces the potential for delays, inconsistencies, and rework. And when that happens, the impact extends beyond internal workflows—affecting study timelines and site experience.

At this point, the question for many organizations is no longer how to optimize these steps, but whether they should remain manual at all.

Rethinking the process—not just improving it

This is where the conversation is starting to shift.

Rather than continuing to refine manual workflows, organizations are beginning to rethink the process itself—looking for ways to reduce the burden of protocol interpretation and data entry entirely.

One of the most impactful developments is CTFS GrantPlan’s Protocol Ingestion—using AI to extract study details, procedures, and schedules directly from the protocol to create a structured starting point for budget development.

But the real value is not just speed. It’s how this changes the role of the user.

Instead of focusing on setup and transcription, teams can shift toward validation and oversight—ensuring budgets are accurate, consistent, and aligned with real-world considerations.

This reflects a broader evolution in clinical operations:
not removing human expertise, but redefining where it adds the most value.

In practice, this can mean:

• Less time spent interpreting and transcribing protocols
• Faster alignment with fair market value benchmarks
• Greater focus on quality, consistency, and decision-making

Importantly, this approach also addresses a common concern: how to introduce automation without sacrificing control.

By combining automated extraction with structured user validation, teams retain oversight while improving efficiency—leading to more consistent and repeatable outcomes over time.

From disconnected tasks to connected workflows

Even when individual steps are improved, budgeting rarely exists in isolation. It sits within a broader workflow that includes site setup, negotiations, contracting, and payments—and this is often where additional friction emerges. In many organizations, budgeting and study startup activities remain fragmented across systems, spreadsheets, and functional teams, creating manual handoffs, duplicated effort, and limited visibility into progress.

An integrated, end-to-end approach helps address this.

With Protocol Ingestion as a starting point, AI-driven extraction can populate key study details and visit schedules. From there, teams can validate and refine data, and move directly into site budget development and negotiations. Integration with clinical trial management systems helps ensure alignment across study and site data.

The benefit isn’t just speed, it’s continuity. Moving from protocol intake to a reviewable, negotiation-ready budget becomes a more connected, efficient process.

At the same time, expectations around visibility are evolving. Budgeting is no longer treated as a one-time task, but as a source of insight.

With centralized reporting and benchmark comparisons, teams can:

• Evaluate costs across studies
• Identify trends and variation
• Support more informed planning and forecasting

This shift—from budgeting as a task to budgeting as a strategic input—is becoming increasingly important as organizations look to optimize performance across their portfolios.

Conclusion

The challenge in clinical trial budgeting isn’t expertise—it’s how much of that expertise is tied up in manual work.

As trials become more complex and timelines continue to compress, that imbalance becomes harder to ignore.

What is emerging instead is a more balanced model: one where automation accelerates data extraction and setup, and experts focus on validation, quality, and strategy.

The organizations that will move fastest in this environment are those that rethink not just how budgets are built, but how expertise is applied across the process.

That is where the future of grant planning is headed—toward workflows that are not only faster, but more connected, consistent, and strategic.

Explore how IQVIA CTFS GrantPlan is helping organizations rethink grant planning—bringing greater efficiency, visibility, and control to clinical trial budgeting. Connect with our team to continue the conversation.